Study identifies cause of immune effector cell-associated enterocolitis after CAR T cell therapy
Patients with multiple myeloma who developed a serious gastrointestinal side effect after treatment with chimeric antigen receptor (CAR) T cell therapy had significantly more CAR T cells persisting in their blood stream, according to new research from The University of Texas MD Anderson Cancer Center.
Read original article on The Medical News →